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Insuiin-like growth factor II (IGF-II) and mannose 6-pbosphate (man-6-P) bind to distinct sites on the same receptor 4,16,20. In the present 
study, we examined the effects of man-6-P on the growth promoting effects of IGF-II on SH-SYSY cultured human neuroblastoma cells. 
Man-6-P alone increased cell number and neurite outgrowth by approximately 50%; as previously observed 12,18,27,30 IGF-II increased cell 
number and neurite outgrowth by approximately 110 and 30%, respectively. However, when cells were grown in the presence of both ligands, 
cell number increased by 330% and neurite outgrowth by 130%. These results suggest that man-6-P can potentiate the known growth pro- 
moting effects of IGF-II on human neuroblastoma cells. Furthermore, they indicate that the IGF-II/man-6-P receptor may serve as a means 
of integrating distinct growth promoting signals in neuronal cells. 
INTRODUCTION 
Insulin-like growth factor-I  and - I I  ( IGF-I  and IGF-  
II)  are peptides with both growth-promoting and insu- 
lin-like activity 6'9"34. In vitro, both  IGF- I  and I G F - I I  are 
mitogenic for neurons ~°'12'~s and stimulate neuritic out- 
growth 19'27'29'3°. The  actions of  the I G F  peptides are me- 
diated by specific cell surface receptors 6'7'9'34. The type 
I I G F  receptor  is structurally and functionally similar to 
the insulin receptor  34 and receptor  binding results in au- 
tophosphorylat ion of  tyrosine residues. The type I I  I G F  
receptor,  unrelated to the IGF- I  and insulin receptor ,  is 
identical to the mannose  6-phosphate (man-6-P) recep- 
tor 1'x5'16'2°. The  IGF-I I /man-6-P  receptor ,  with separate  4 
but cooperat ive binding sites for  both  IGF- I I  and man-  
6-P 33, mediates  intracellular and extracellular targeting 
of lysosomal enzymes via the man-6-P binding site s. 
IGF- I I ,  coupling to its distinct site on the IGF-I I /man-  
6-P receptor ,  can stimulate D N A  synthesis 3, increase 
amino acid uptake  2'13, enhance Ca 2+ inttux 22 and acti- 
vate G proteins 23'24. The  biological significance of one 
receptor  capable  of  binding both IGF- I I  and man-6-P 
remains uncertain. Recent  work,  however ,  suggests the 
IGF-I I /man-6-P  may  play a role in integrating multiple 
growth-promoting signals. Secreted man-6-P containing 
proteins,  including transforming growth factor-il l  pre- 
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cursor 26, proliferin 14 and cathepsin D 17 c a n  bind the 
man-6-P site of  the IGF-I I /man-6-P  receptor  and serve  
as autocrine growth factors 17. 
In the present  study, we examined the effects of  man- 
6-P in conjuction with IGF- I I  on SH-SYSY human neu- 
roblas toma cell mitogenesis and neuritic outgrowth.  This 
cell line serves as a good model  for the growth-promot-  
ing effects of  the insulin-like growth factors. Both IGF-I  
and IGF- I I  receptors are present  on SH-SYSY cells 2s, 
which are stimulated to undergo mitogenesis 12'is as well 
as vigorous neuritic outgrowth 19'27'29'3° by both peptides.  
We repor t  that  man-6-P alone can enhance both neuro- 
blastoma mitogenesis and neuritic outgrowth,  and in the 
presence of IGF- I I ,  these effects are potentiated.  We 
speculate that  man-6-P-containing proteins may  act in an 
autoerine or  paracrine fashion, in concert  with IGF- I I ,  
to regulate neuronal  growth. 
MATERIALS AND METHODS 
Materials 
Human recombinant IGF-II (Baehem, Torrance, CA) was dis- 
solved in 10 mM acetic acid and stored at -20 *C. D-Man-6-P was 
purchased from Sigma Chemicals, St. Louis, MO. 
Cell culture 
Human SH-SY5Y neuroblastoma cells were kindly provided by 
Dr. Stephen Fisher, University of Michigan Medical Center. Cells 
University of Michigan, 1103 E. Huron Street, Ann Arbor, MI 
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were maintained in plastic tissue culture flasks in Dulbecco's Mod- 
ified Eagle's Medium (DMEM) supplemented with 10% calf serum 
(CS). Cells were maintained in an atmosphere of 5% CO 2 and 95% 
humidified air. 
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Growth  studies ~ 
To determine cell doubling, 3 × 105 cells were seeded in 3.5 cm 
culture wells in DMEM supplemented with 2 mg/ml glucose and 
10% CS. After 3 days in culture, cells were rinsed with 1 ml of 
warm serum-free DMEM before adding 3 ml warm DMEM con- 
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Fig. 1. Effect of man-6-P and IGF-II on SH-SY5Y neuroblastoma doubling. 3 x 105 cells were seeded in DMEM with 10% CS. After 3 days 
in culture, cells were rinsed with warm serum-free DMEM and placed in DMEM alone ( I ) ,  5 mM man-6-P(l~}. 10 nM IGF-II (I~l)and 5 
mM man-6-P plus 10 nM IGF-II ( IrA )Top: cell doubling was measured as described in Materials and Methods on days 1, 2, 3, 5 and 7, with 
a media change on day 4. Values are means + S.E.M. of triplicate replicates, from one of 3 experiments which gave similar results. Bottom: 




Effect o f  man-6-P and 1GF-H on DNA content 
Cells were seeded and cultured as described in Fig. 1. At the indicated days, an aliquot of suspended cells was pelleted and DNA ~g)  
was determined as described in Materials and Methods. Results are means -+ S.E.M. of triplicate replicates, from one of 3 experiments 
which gave similar results. 
Days 
1 2 3 5 7 
Man-6-P 8.8 -+ 0.5 10.9 -+ 1.7 12.2 -+ 1.5 12.0 +- 1.0 13.9 -+ 2.5 
IGF-II 10.0 -+ 0.9 14.6 + 0.3 17.7 + 1.2 20.1 - 2.7 21.2 - 4.6 
Man-6-P + IGF-II 11.4 +- 0.9 14.0 +- 2.9 20.4 --- 1.3 32.2 --- 1.1 50.2 -+ 8.9 
taining the test agents. Each agent was tested in 3 replicate wells. 
A baseline cell count was obtained on the day of dosing and cell 
doubling was measured on days 1,2,3,5 and 7, with a media change 
on day 4. Floating and attached cells were counted. The media 
containing floating cells was transferred from each well to tubes, 
and the attached cells were incubated with 1 ml 0.05% trypsin, 0.53 
mM EDTA at 37 °C for 10 min. After terminating trypsinization 
with 1 ml DMEM with 10% CS, cells were centrifuged for 2 min at 
1000 rpm and the cell pellet resuspended in 0.25 ml Hanks' bal- 
anced salt solution. A 0.1 ml aliquot was taken and viable cells 
were counted in a hemocytometer using Trypan blue dye exclusion. 
The remaining cell suspension was centrifuged at 3000 rpm for 2 
rain and the cell pellet stored at -20 °C for determination of cel- 
lular DNA. 
Neurite outgrowth 2°'23 
For measuring neurite outgrowth, cells were trypsinized as de- 
scribed above, triturated to obtain a single cell suspension and 
seeded into 12-well plates in 1 ml of DMEM with 10% CS. After 3 
days of growth to allow attachment and recovery from trypsiniza- 
tion, the cells were rinsed with 0.5 ml warm serum-free DMEM 
before dosing with 1 ml warm media containing the test agents. 
Neurite outgrowth was measured on days 1, 2, 3, 5 or 7. The per- 
centage of neurite-bearing cells was determined by counting 100 
cells from randomly selected fields in each of 3 culture wells under 
low-power phase contrast microscopy. Cells bearing neurites of 40 
#m or more were scored positively and cells with multiple neurites 
were scored only once. Partially obscured neurites caused by cell 
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Fig. 2. Man-6-P potentiates IGF-II-stimulated neuronal doubling. 
3 x 105 cells were seeded in DMEM with 10% CS. After 3 days in 
culture, cells were rinsed with warm serum-free DMEM and placed 
in DMEM alone (m), 10 nM IGF-II ( 1 ~  10 nM IGF-II plus 5 mM 
mannose(g:l), 10 nM IGF-II plus 5 mM man-l-P (Ir21)and 10 nM 
IGF-II plus 5 mM (man-6-P ( ~ .  Cell doubling was measured as 
described in Materials and Methods on day 7, with a media change 
on day 4. Values are means + S.E.M. of triplicate replicates. 
clustering were not scored. Representative photographs were taken 
of cells in each test condition on days 1, 2, 3, 5 and 7. 
DNA assay 11 
This method involves hydrolysis of purine nucleotides by heat- 
ing, allowing the exposed sugars to react with diaminobenzoic acid 
(DABA). Cell pellets remaining from the cell growth study were 
dissolved in 0.1 ml of 0.1% sodium dodecyl sulfate (SDS). An equal 
volume of decolorized, purified 1.8 M DABA was added to each 
tube. After 30 min at 60 °C, 1.5 ml 1 N HCI was added to each 
tube and wavelength readings were measured in a Shimadzu spec- 
trofluorophotometer (activation 410, emission 502). Calf thymus 
DNA (2 mg/ml in 0.1 N NH4OH ) was used to generate a standard 
c u r v e .  
RESULTS 
Cell  d o u b l i n g  
T h e  effects  of  man-6-P  and I G F - I I  on  neu rona l  dou-  
bl ing are  shown in Fig.  1. In  se rum-f ree  med ia ,  the  cells 
surv ived  for  7 days wi th  no significant change  in cell  
n u m b e r ,  as p rev ious ly  r e p o r t e d  by Sonne fe ld  and  Ishii  35. 
Wi th  the  add i t ion  o f  5 m M  man-6-P,  cell  n u m b e r  re- 
m a i n e d  cons tan t  for  the  first 3 days,  bu t  af ter  the  med ia  
change  on  day 4, the re  was a 55% increase  in cell  num-  
ber  o b s e r v e d  on day 5 which r e m a i n e d  cons tan t  at day 
7. In  the  p resence  o f  10 n M  I G F - I I ,  cell  n u m b e r  in- 
c reased  by 37% by day 2, doub l ed  at day  3 and then  re- 
m a i n e d  constant .  
W h e n  cells were  g rown  in the  p resence  of  bo th  man-  
6-P and I G F - I I ,  neu rona l  n u m b e r  doub led  by day 2, tri- 
p led  by day 3, inc reased  4-fold on  day 5 and 7-fold on  
day 7. T h e  effects  on  neu rona l  g rowth  o f  man-6-P  and 
I G F - I I  t oge the r ,  w h e n  c o m p a r e d  with  each  fac tor  sepa-  
ra te ly ,  w e r e  m o r e  than  addi t ive  on  day 7. D N A  deter -  
mina t ions  conf i rmed  cell  counts  (Table  I). These  effects  
were  specific for  man-6-P  and  did no t  occur  in the  pres-  
ence  o f  m a n n o s e  o r  m a n n o s e - l - P  ( m a n - l - P )  (Fig. 2). 
Concen t r a t i ons  b e t w e e n  5 /~M and  5 m M  of  man-6-P  
were  not  toxic  to  the  cells  (Fig. 3 A )  and cell  dea th  wi th  
co r r e spond ing  decreases  in to ta l  D N A  (Fig. 3B) were  
o b s e r v e d  only  at concen t r a t i ons  equa l  to o r  g rea te r  than  
10 m M  man-6-P.  
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The effects of man-6-P and IGF-I on neuronal dou- 
bling are presented in Table II. There was no difference 
between 1, 3 or 10 nM IGF-I alone, 5 mM man-6-P, or 
1 and 3 nM IGF-I plus 5 mM man-6-P on neuronal dou-’ 
bling at day 7. However, cell number more than dou- 
bled in the presence of 10 nM IGF-I and 5 mM man-6-P 
compared to each factor separately. 
Neurite outgrowth 
The effects of man-6-P and IGF-II on neurite out- 
growth are shown in Fig. 4. In serum-free conditions, 
neurite formation remained stable between days 1 and 
3, averaging 35%. After media change, neurite outgrowth 
decreased by 10% on day 5, but returned to baseline on 
day 7. Man-6-P enhanced neurite outgrowth to 50% on 
day 1. This effect was lost by day 2, when neurite out- 
growth decreased to 40% where it remained throughout 
the study. In the presence of IGF-II, neurite outgrowth 
2ti 
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Fig. 3. Effect of man-6-P on SH-SYSY neuroblastoma doubling. 3 
x 10’ cells were seeded in DMEM with 10% CS. After 3 days in 
culture, cells were rinsed with warm serum-free DMEM and grown 
in DMEM plus different concentrations of man-6-P. A: cell dou- 
bling was measured as described in Materials and Methods on day 
3. Values are means f S.E.M. of 3 replicate cultures. Cell death 
was first observed at 10 mM man-6-P. B: DNA determinations were 
performed after the doubling measurements on each of 3 replicate 
cultures as described in Materials and Methods. Mean DNA val- 
ues are expressed as the percent change of the average DNA value 
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Fig. 4. Effect of man-6-P and IGF-II on SH-SYSY neuroblastoma 
neurite outgrowth. 1 x lo4 cells were seeded in DMEM with 10% 
CS. After 3 days in culture, cells were rinsed with warm serum- 
free DMEM and placed in DMEM alone (m), 5 mM man-6-P (0) 
10 nM IGF-II (@) and 5 mM man-6-P plus 10 nM IGF-II (A). 
Neurite outgrowth was measured as described in Materials and 
Methods. Values are means k S.E.M. of triplicate results, from 
one of 3 experiments which gave similar results. Statistical signifi- 
cance was determined with the Student’s t-test. aP < 0.01 compared 
to SF DMEM cultures on days 1 and 5; bF < 0.01 compared to SF 
DMEM cultures on days l-5; ‘P < 0.01 compared to SF DMEM 
cultures on days 1-7. 
increased linearly over time, reaching 60% by day 3. Af- 
ter media change on day 4, outgrowth on day 5 remained 
stable at 57%, but declined to 39% on day 7. In the 
presence of both man-6-P and IGF-II, neurite outgrowth 
averaged 50% between days 1 and 3. After media change 
on day 4, outgrowth increased to 72%, and by day 7, 
peaked at 80%. 
DISCUSSION 
The man-6-P receptor is structurally and functionally 
identical to the receptor for IGF-I116~20, a polypeptide 
with mitogenic activity 6,9,10,12*18*34. This multifunctional 
receptor, with distinct but cooperative binding sites for 
both man-6-P and IGF-I14,33, mediates intracellular and 
extracellular targeting of man-6-P-containing proteins via 
TABLE II 
Effect of man-6-P and IGF-I on SH-SYSY neuroblastoma dou- 
bling 
3 x 10’ cells were seeded in DMEM with 10% CS. After 3 days 
in culture, cells were rinsed with warm serum-free DMEM and 
placed in DMEM alone; 5 mM man-6-P; 1, 3 or 10 nM IGF-I: 
and 5 mM man-6-P plus 1, 3 or 10 nM IGF-I. Values are means 
x 16 + S.E.M. of triplicate replicates, from one of two experi- 
ments which gave similar results. 
_--.. 
Concentration of IGF-I 
_- 
I nM 3 nM IO nM 
Man-6-P 8.7 2 0.9 9.8 t 1.0 8.0 k 0.6 
IGF-I 8.5 -+ 0.8 12.3 k 1.0 8.9 k 2.4 
Man-6-P + IGF-I 10.6 k 1.8 12.9 c 0.6 20.3 2 1.4 
_ ._..-. 
the man-6-P binding site 8. Transmembrane signalling of 
IGF-II's growth promoting effects can occur via the 
IGF-II binding site 2'3'7'13"17'23'24. Thus, the man-6-P/ 
IGF-II receptor can serve as a way to integrate the dy- 
namic function of glycoproteins with growth factor sig- 
naling and may play a key role in the life cycle of a 
neuron. We postulated that man-6-P might have a direct 
effect on neuroblastoma cells and modulate the known 
mitogenic 12'18 and neurite promoting 19'27"29"3° effects of 
IGF-II on these cells. 
"Man-6-P alone stimulated SH-SY5Y neuroblastoma 
doubling in a dose-dependent fashion. At concentrations 
less than 5 aM, man-6-P had no effect on neuroblastoma 
doubling while concentrations equal to or greater than 
10 mM were toxic to the cells. Between 5 pM and 5 mM, 
man-6-P enhanced neuronal doubling, while 5 mM man- 
nose and man-l-P had no effect. Nielsen and Gammel- 
tort 21 reported a similar stimulation by man-6-P of rat 
brain neuronal precursor cells. This stimulation was in- 
hibited by antiserum specific for the man-6-P/IGF-II re- 
ceptor. The mitogenic effect of man-6-P on neuroblas- 
toma cells (our data) and neuronal precursor cells (ref. 
21) suggests that man-6-P-containing proteins could mod- 
ulate neuronal growth via the IGF-II/man-6-P receptor. 
Mitogenic man-6-P-containing proteins have been iden- 
tified, including transforming growth factor-ill precur- 
sor 26 and proliferin 14, which bind to the IGF II/man-6-P 
receptor and activate phospholipase C 32. A third man- 
6-P-containing protein is a lysosomal enzyme known as 
cathepsin D. Cathepsin D binds the IGF-II/man-6-P re- 
ceptor, stimulates cellular growth and alters IGF-II me- 
diated cell doubling ~7"36, supporting our tenet that dis- 
tinct ligands can effect growth via binding to the 
multifunctional IGF-II/man-6-P receptor. 
In agreement with Ishii and associates 12"18"19"27"29"3°, 
we found that the IGFs stimulated SH-SY5Y neuroblas- 
toma doubling and neurite outgrowth. Our data suggests 
that man-6-P potentiates these IGF induced cellular re- 
sponses via the IGF II/man-6-P receptor. In SH-SY5Y 
neuroblastoma cells, the half-maximal displacement of 
125I-IGF-I by its unlabeled ligand is 2-5 nM while 10 nM 
IGF-I occupies over 50% of the IGF-II receptor sites 28. 
Man-6-P did not potentiate IGF-I stimulated neuronal 
doubling when the growth factor was present at 1 or 3 
nM, concentrations at which IGF-I preferentially binds 
IGF-I receptors in neuroblastoma cells 2s. In contrast, at 
10 nM IGF-I, where there is significant cross-occupancy 
of IGF-I with the IGF-II receptor 28, we observed man- 
6-P potentiation of growth factor induced doubling. Sim- 
ilarly, after 7 days in culture, addition of either man-6-P 
or IGF-II stimulated neuronal doubling by 42% and 
110%, respectively. However, when added together, 
man-6-P and IGF-II increased cell number by 335%, a 
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response much larger than can be accounted for by a 
simple additive effect. In parallel, by day 7, addition of 
either man-6-P or IGF-II-stimulated neurite outgrowth 
by approximately 30%, while together, man-6-P and 
IGF-II enhanced outgrowth by 132%. 
There are other biological examples of man-6-P po- 
tentiation of signal transduction by the IGF-II/man-6-P 
receptor, including phospholipase C activation by IGF- 
II 31, transforming growth factor-ill precursor and pro- 
liferin 32. In these studies and in our own work, the 
mechanism which underlies man-6-P potentiation is not 
determined, but several possibilities exist. Potentiation 
could result from a man-6-P enhancement of available 
man-6-P/IGF-II cell surface receptors. In our studies, the 
effects of man-6-P were most pronounced in cells which 
had been in culture for 5 or more days, suggesting in- 
creased receptor availability over time. This phenome- 
non is reported in fibroblasts, where binding of man-6-P 
to the IGF-II/man-6-P receptor triggers redistribution of 
the receptor to the cell surface, increasing available 
ligand binding sites 5. Alternatively, man-6-P may di- 
rectly enhance IGF-II binding by displacing inhibitory 
ligands 25 or increasing the affinity of IGF-II for its re- 
ceptor 33. While these explanations remain plausible for 
our studies, they cannot explain the mechanism of man- 
6-P-potentiated IGF-II phospholipase C activation in the 
kidney, reported by Rogers and Hammerman 31. In this 
model, man-6-P-potentiated IGF-II induced phospholi- 
pase C activation by 215% while specific IGF-II binding 
was increased by only 26%. Furthermore, man-6-P de- 
creased transforming growth factor-ill precursor and 
proliferin binding to the IGF-II/man-6-P receptor, but 
potentiated peptide stimulated renal phospholipase C ac- 
tivation 32. It is possible that potentiation of phospholi- 
pase C activity (Hammerman's studies) and of neuro- 
blastoma doubling and neuritic outgrowth (our studies) 
reflects an action of man-6-P to directly enhance IGF-II 
signal transduction. Further studies are needed to ad- 
dress these issues. 
In summary, the IGF-II/man-6-P receptor is a multi- 
functional protein capable of binding both IGF-II and 
man-6-P 16"2°. In human cultured neuroblastoma cells, 
man-6-P stimulated mitogenesis and neurite outgrowth 
and potentiated the known growth promoting effects of 
IGF-II. We speculate that the IGF-II/man-6-P receptor 
can serve as a way to integrate signaling from glycopro- 
teins, including man-6-P containing growth factors, and 
IGF-II in neuronal cells. 
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